Published in Gastroenterol Clin North Am on March 01, 2008
Chromoendoscopy for Serrated Polyposis Syndrome (SERRADA) | NCT03476434
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01
Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology (2011) 1.86
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet (2012) 1.63
Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol (2012) 1.59
Finding sessile serrated adenomas: is it possible to identify them during conventional colonoscopy? Dig Dis Sci (2014) 1.41
Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev (2010) 1.19
Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut (2012) 1.07
A case of cronkhite-Canada syndrome and a review of gastrointestinal polyposis syndromes. Gastroenterol Hepatol (N Y) (2012) 1.05
Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf) (2015) 1.05
Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J Gastroenterol (2012) 1.03
Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol (2012) 1.02
Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Patholog Res Int (2011) 1.01
Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00
Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol (2012) 1.00
Polyp size measurement at CT colonography: what do we know and what do we need to know? Radiology (2010) 1.00
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology (2011) 1.00
Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol (2013) 0.99
Risk factors: Hyperplastic polyposis syndrome and risk of colorectal cancer. Nat Rev Gastroenterol Hepatol (2010) 0.99
Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol (2012) 0.97
Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96
Significance of serrated polyps of the colon. Curr Gastroenterol Rep (2008) 0.96
Cronkhite-Canada syndrome: review of the literature. Gastroenterol Res Pract (2013) 0.91
Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol (2013) 0.91
Improving the accuracy of CTC interpretation: computer-aided detection. Gastrointest Endosc Clin N Am (2010) 0.90
Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer (2011) 0.89
Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam Cancer (2009) 0.87
miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol (2011) 0.86
Serrated polyps of right colon: guilty or innocent? Ann Gastroenterol (2013) 0.84
Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives. Fam Cancer (2013) 0.83
Adiposity in relation to colorectal adenomas and hyperplastic polyps in women. Cancer Causes Control (2009) 0.81
Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract (2015) 0.81
Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability. J Cancer Res Clin Oncol (2010) 0.81
Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol Med (2016) 0.80
Hyperplastic Polyposis Syndrome Identified with a BRAF Mutation. Gut Liver (2012) 0.79
CT colonography and cost-effectiveness. Eur Radiol (2008) 0.78
Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer. Future Oncol (2010) 0.78
Molecular classification of colorectal carcinomas: the genotype-to-phenotype relation. World J Gastroenterol (2013) 0.77
Serrated polyposis is an underdiagnosed and unclear syndrome: the surgical pathologist has a role in improving detection. Am J Surg Pathol (2012) 0.77
Serrated polyps of the colon. F1000 Med Rep (2010) 0.77
British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut (2017) 0.76
Sessile serrated adenomas: why conventional endoscopy is okay for unconventional polyps. Dig Dis Sci (2014) 0.76
The clinical impact of serrated colorectal polyps. Clin Epidemiol (2017) 0.75
Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity. Oncol Lett (2016) 0.75
Three Colon Adenocarcinomas Arising in a Patient with Serrated Polyposis Syndrome: Case Report and Review of the Literature. Viszeralmedizin (2014) 0.75
Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol (2015) 0.75
Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp. Can J Gastroenterol Hepatol (2017) 0.75
Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients. Intest Res (2017) 0.75
[Colorectal polyposis syndrome: a guide to diagnosis]. Pathologe (2011) 0.75
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut (2010) 6.34
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91
Optical diagnosis of small colorectal polyps at routine colonoscopy (Detect InSpect ChAracterise Resect and Discard; DISCARD trial): a prospective cohort study. Lancet Oncol (2009) 3.86
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med (2008) 3.76
Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol (2005) 3.29
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol (2005) 3.19
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology (2006) 2.63
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology (2007) 2.39
Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc (2010) 2.38
Dynamic patient position changes during colonoscope withdrawal increase adenoma detection: a randomized, crossover trial. Gastrointest Endosc (2010) 2.28
Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc (2004) 2.27
Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol (2004) 2.27
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol (2006) 2.17
Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc (2013) 2.16
Simulator training improves practical skills in therapeutic GI endoscopy: results from a randomized, blinded, controlled study. Gastrointest Endosc (2009) 2.15
Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol (2006) 2.12
Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology (2012) 2.11
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
Comparison of magnified pit pattern interpretation with narrow band imaging versus chromoendoscopy for diminutive colonic polyps: a pilot study. Gastrointest Endosc (2007) 2.07
Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol (2005) 2.03
A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol (2007) 1.71
Endoscopic mucosal resection of 161 cases of large sessile or flat colorectal polyps. Scand J Gastroenterol (2007) 1.71
Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res (2002) 1.67
Position changes improve visibility during colonoscope withdrawal: a randomized, blinded, crossover trial. Gastrointest Endosc (2006) 1.58
Surface visualization at CT colonography simulated colonoscopy: effect of varying field of view and retrograde view. Am J Gastroenterol (2007) 1.57
Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc (2002) 1.50
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol (2013) 1.47
Treatment with argon plasma coagulation reduces recurrence after piecemeal resection of large sessile colonic polyps: a randomized trial and recommendations. Gastrointest Endosc (2002) 1.46
Multi-detector row CT colonography: effect of collimation, pitch, and orientation on polyp detection in a human colectomy specimen. Radiology (2003) 1.44
Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients. Scand J Gastroenterol (2006) 1.41
The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev (2006) 1.41
Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int J Cancer (2011) 1.40
Colorectal stenting for malignant and benign disease: outcomes in colorectal stenting. Dis Colon Rectum (2004) 1.37
Acceptance by patients of multidetector CT colonography compared with barium enema examinations, flexible sigmoidoscopy, and colonoscopy. AJR Am J Roentgenol (2003) 1.27
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
Colonoscopy at a combined district general hospital and specialist endoscopy unit: lessons from 505 consecutive examinations. J R Soc Med (2002) 1.27
A new prognostic staging system for rectal cancer. Ann Surg (2004) 1.26
Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer (2004) 1.26
Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA (2005) 1.24
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res (2008) 1.23
Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol (2012) 1.22
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol (2007) 1.22
Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases. Clin Cancer Res (2003) 1.22
Emerging pathways in colorectal-cancer development. Lancet Oncol (2002) 1.20
The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res (2003) 1.18
Development and validation of a training module on the use of narrow-band imaging in differentiation of small adenomas from hyperplastic colorectal polyps. Gastrointest Endosc (2011) 1.17
Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer (2008) 1.15
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res (2008) 1.15
The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol (2007) 1.14
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod Pathol (2007) 1.13
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Cancer (2008) 1.12
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway. Eur J Cancer (2007) 1.10
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis (2008) 1.09
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res (2005) 1.07
Effect of magnetic endoscope imaging on patient tolerance and sedation requirements during colonoscopy: a randomized controlled trial. Gastrointest Endosc (2002) 1.05
Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol (2012) 1.04
Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer. Am J Clin Pathol (2003) 1.03
Colonoscopic balloon dilation of Crohn's strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol (2003) 1.03
Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc (2009) 1.02
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. Mod Pathol (2006) 1.01
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer. Mod Pathol (2006) 1.01
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol (2012) 1.00
Development and validation of a novel method for assessing competency in polypectomy: direct observation of polypectomy skills. Gastrointest Endosc (2011) 0.98
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer. Eur J Cancer (2007) 0.96
Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum (2006) 0.93
Factors associated with failed polyp retrieval at screening colonoscopy. Gastrointest Endosc (2012) 0.93
DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. Int J Cancer (2006) 0.92
Aids to insertion: magnetic imaging, variable stiffness, and overtubes. Gastrointest Endosc Clin N Am (2005) 0.92
A new accessory, endoscopic cuff, improves colonoscopic access for complex polyp resection and scar assessment in the sigmoid colon (with video). Gastrointest Endosc (2012) 0.92
Advances in colonic imaging: technical improvements in colonoscopy. Eur J Gastroenterol Hepatol (2005) 0.92
The variable stiffness colonoscope: assessment of efficacy by magnetic endoscope imaging. Gastrointest Endosc (2002) 0.92
The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch (2007) 0.91
Endoscopic mucosal ablation: a new argon plasma coagulation/injection technique to assist complete resection of recurrent, fibrotic colon polyps (with video). Gastrointest Endosc (2011) 0.91
Use of video and magnetic endoscope imaging for rating competence at colonoscopy: validation of a measurement tool. Gastrointest Endosc (2002) 0.90
Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes. Pathology (2002) 0.90
High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families. Hum Mutat (2009) 0.89
HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers. Int J Cancer (2009) 0.89
Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis (2003) 0.89
Large villous adenomas arising in ileal pouches in familial adenomatous polyposis: report of two cases. Dis Colon Rectum (2004) 0.88
Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response. Dis Colon Rectum (2007) 0.88
Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). Fam Cancer (2011) 0.87
Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam Cancer (2009) 0.87
MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells. Cancer Immunol Immunother (2008) 0.86
Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum (2005) 0.86
The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability. Hum Pathol (2007) 0.86
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers. BMC Cancer (2006) 0.86
Hyperplastic polyposis and cancer of the colon with gastrinoma of the duodenum. Nat Clin Pract Oncol (2006) 0.85
Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. J Pathol (2003) 0.85
Re: Ward et al. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 2005;207:377-384. J Pathol (2006) 0.84
A novel method of treating colonic angiodysplasia. Gastrointest Endosc (2006) 0.83
Computer-aided learning in capsule endoscopy leads to improvement in lesion recognition ability. Gastrointest Endosc (2009) 0.83
Correspondence re: P. Laiho et al., Low-level microsatellite instability in most colorectal carcinomas. Cancer Res., 62: 1166-1170, 2002. Cancer Res (2002) 0.82
Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer. Clin Cancer Res (2004) 0.82
Heterogeneous microsatellite instability observed within epithelium of ulcerative colitis. Int J Cancer (2006) 0.81
Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer. Dis Colon Rectum (2006) 0.80
Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potential. J Gastrointest Surg (2006) 0.80